Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Chemoprevention in Lynch syndrome.

Burn J, Mathers JC, Bishop DT.

Fam Cancer. 2013 Dec;12(4):707-18. doi: 10.1007/s10689-013-9650-y.

PMID:
23880960
[PubMed - indexed for MEDLINE]
2.

Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).

Burn J, Mathers J, Bishop DT.

Recent Results Cancer Res. 2013;191:157-83. doi: 10.1007/978-3-642-30331-9_9. Review.

PMID:
22893205
[PubMed - indexed for MEDLINE]
3.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L, Bisgaard ML, Dunlop MG, Ho JW, Hodgson SV, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen HF, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen JT, Fodde R, Lynch HT, Mathers JC, Bishop DT; CAPP2 Investigators.

Lancet. 2011 Dec 17;378(9809):2081-7. doi: 10.1016/S0140-6736(11)61049-0. Epub 2011 Oct 27.

PMID:
22036019
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Mathers JC, Movahedi M, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans G, Maher ER, Bertario L, Bisgaard ML, Dunlop M, Ho JW, Hodgson S, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen H, Gerdes AM, Barker G, Crawford G, Elliott F, Pylvanainen K, Wijnen J, Fodde R, Lynch H, Bishop DT, Burn J; CAPP2 Investigators.

Lancet Oncol. 2012 Dec;13(12):1242-9. doi: 10.1016/S1470-2045(12)70475-8. Epub 2012 Nov 7.

PMID:
23140761
[PubMed - indexed for MEDLINE]
Free Article
5.

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.

Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, Eccles D, Ellis A, Evans DG, Fodde R, Maher ER, Möslein G, Vasen HF, Coaker J, Phillips RK, Bülow S, Mathers JC; International CAPP consortium.

Cancer Prev Res (Phila). 2011 May;4(5):655-65. doi: 10.1158/1940-6207.CAPR-11-0106.

PMID:
21543343
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

PMID:
20594533
[PubMed - indexed for MEDLINE]
Free Article
7.

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JW, Vasen HF, Side L, Thomas HJ, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC; CAPP2 Investigators.

N Engl J Med. 2008 Dec 11;359(24):2567-78. doi: 10.1056/NEJMoa0801297. Erratum in: N Engl J Med. 2009 Apr 2;360(14):1470.

PMID:
19073976
[PubMed - indexed for MEDLINE]
Free Article
8.

Lynch syndrome: history, causes, diagnosis, treatment and prevention (CAPP2 trial).

Burn J, Mathers J, Bishop DT.

Dig Dis. 2012;30 Suppl 2:39-47. doi: 10.1159/000341892. Epub 2012 Nov 23.

PMID:
23207931
[PubMed - indexed for MEDLINE]
9.

Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome.

Barton MK.

CA Cancer J Clin. 2012 May-Jun;62(3):143-4. doi: 10.3322/caac.21136. Epub 2012 Mar 12. No abstract available.

PMID:
22411104
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

Topping DL, Bird AR, Young GP.

N Engl J Med. 2009 Apr 2;360(14):1462; author reply 1462-3. No abstract available.

PMID:
19348022
[PubMed - indexed for MEDLINE]
11.

Aspirin and colorectal cancer prevention in Lynch syndrome.

Chan AT, Lippman SM.

Lancet. 2011 Dec 17;378(9809):2051-2. doi: 10.1016/S0140-6736(11)61216-6. Epub 2011 Oct 27. No abstract available.

PMID:
22036018
[PubMed - indexed for MEDLINE]
12.

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

Yang F, Jin C, Fu D.

N Engl J Med. 2009 Apr 2;360(14):1461-2; author reply 1462-3. doi: 10.1056/NEJMc090032. No abstract available.

PMID:
19339729
[PubMed - indexed for MEDLINE]
Free Article
13.

Aspirin may help colon cancer patients live longer.

[No authors listed]

Harv Health Lett. 2013 Jan;38(3):8. No abstract available.

PMID:
23556168
[PubMed - indexed for MEDLINE]
14.

Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model.

McIlhatton MA, Tyler J, Kerepesi LA, Bocker-Edmonston T, Kucherlapati MH, Edelmann W, Kucherlapati R, Kopelovich L, Fishel R.

Cancer Prev Res (Phila). 2011 May;4(5):684-93. doi: 10.1158/1940-6207.CAPR-10-0319. Epub 2011 Mar 24.

PMID:
21436383
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Aspirin in the chemoprevention of colorectal neoplasia: an overview.

Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, Logan RF, Rothwell PM, Schrör K, Baron JA.

Cancer Prev Res (Phila). 2012 Feb;5(2):164-78. doi: 10.1158/1940-6207.CAPR-11-0391. Epub 2011 Nov 14. Review.

PMID:
22084361
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

Flossmann E, Rothwell PM; British Doctors Aspirin Trial and the UK-TIA Aspirin Trial.

Lancet. 2007 May 12;369(9573):1603-13. Review.

PMID:
17499602
[PubMed - indexed for MEDLINE]
17.

Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.

Ishikawa H, Wakabayashi K, Suzuki S, Mutoh M, Hirata K, Nakamura T, Takeyama I, Kawano A, Gondo N, Abe T, Tokudome S, Goto C, Matsuura N, Sakai T.

Cancer Med. 2013 Feb;2(1):50-6. doi: 10.1002/cam4.46. Epub 2013 Feb 3.

PMID:
24133627
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Does aspirin really reduce the risk of colon cancer?

Cleland JG.

Lancet. 2012 Apr 28;379(9826):1586; author reply 1587. doi: 10.1016/S0140-6736(12)60671-0. Epub 2012 Apr 26. No abstract available.

PMID:
22541575
[PubMed - indexed for MEDLINE]
19.

Does aspirin really reduce the risk of colon cancer?

Jankowski J, Barr H, Moayyedi P.

Lancet. 2012 Apr 28;379(9826):1586-7; author reply 1587. doi: 10.1016/S0140-6736(12)60672-2. Epub 2012 Apr 26. No abstract available.

PMID:
22541573
[PubMed - indexed for MEDLINE]
20.

Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.

Sandler RS.

Important Adv Oncol. 1996:123-37. Review.

PMID:
8791132
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk